Evidence map›Paper›PMID 27077228›Full record

ArticleJournal of medicinal chemistry2016

Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study.

Sandeep Rana, Elizabeth C Blowers, Calvin Tebbe, Jacob I Contreras, Prakash Radhakrishnan, Smitha Kizhake, Tian Zhou, Rajkumar N Rajule, Jamie L Arnst, Adnan R Munkarah and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Thiazole, Isatin and Phthalimide Derivatives TestedCurrent medicinal chemistry · 2024
    Review
  7. Article
  8. RSC medicinal chemistry · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sandeep Rana
Elizabeth C Blowers
Calvin TebbeDivision of Gynecology Oncology, Department of Women's Health and Josephine Ford Cancer Center, Henry Ford Hospital , Detroit, Michigan 48202, United States.
Jacob I Contreras
Prakash Radhakrishnan
Smitha Kizhake
Tian Zhou
Rajkumar N Rajule
Jamie L Arnst
Adnan R MunkarahDivision of Gynecology Oncology, Department of Women's Health and Josephine Ford Cancer Center, Henry Ford Hospital , Detroit, Michigan 48202, United States.
Ramandeep RattanDivision of Gynecology Oncology, Department of Women's Health and Josephine Ford Cancer Center, Henry Ford Hospital , Detroit, Michigan 48202, United States.
Amarnath Natarajan
University of Nebraska Medical Center · USHenry Ford Hospital · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Joann B. Sweasy · 1985 to 2026
$55.0M
Tissue CoreP50CA127297 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI HOLLINGSWORTH, MICHAEL A. · 2008 to 2018
$17.1M
CHEMICAL CARCINOGENESIS &CANCER BIOLOGYT32CA009476 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Jennifer D. Black · 1988 to 2026
$6.2M
Phosphorylated Form of Activated IKKbeta and Pancreatic CancerR21CA182820 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI NATARAJAN, AMARNATH (AMAR) · 2014 to 2015
$440k
NCI NIH HHS P30 CA036727NCI NIH HHS P50 CA127297NCI NIH HHS R21 CA182820NCI NIH HHS T32 CA009476
6 · The paper itself

Abstract

Design, synthesis, and evaluation of α-methylene-γ-butyrolactone analogues and their evaluation as anticancer agents is described. SAR identified a spirocyclic analogue 19 that inhibited TNFα-induced NF-κB activity, cancer cell growth and tumor growth in an ovarian cancer model. A second iteration of synthesis and screening identified 29 which inhibited cancer cell growth with low-μM potency. Our data suggest that an isatin-derived spirocyclic α-methylene-γ-butyrolactone is a suitable core for optimization to identify novel anticancer agents.

Indexed as

Antineoplastic AgentsCell Line, TumorCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorHumansIsatinMolecular StructureNF-kappa BSpiro CompoundsStructure-Activity RelationshipTumor Necrosis Factor-alphaAntineoplastic AgentsIsatinNF-kappa BSpiro CompoundsTumor Necrosis Factor-alpha

Identifiers

PMID27077228
PMCPMC5273401
OpenAlexW2336869895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.